Protalix BioTherapeutics Inc (PLX)
1.41
-0.07
(-4.73%)
USD |
NYAM |
Jul 11, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Market Cap: 112.25M for July 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AIM ImmunoTech Inc | 6.947M |
| Perspective Therapeutics Inc | 295.43M |
| Electromed Inc | 160.01M |
| Xtant Medical Holdings Inc | 91.26M |
| Armata Pharmaceuticals Inc | 80.35M |
Market Cap Related Metrics
| PE Ratio | 35.25 |
| PS Ratio | 1.979 |
| PEG Ratio | 0.1175 |
| Price to Book Value | 2.483 |
| Price | 1.41 |
| Earnings Yield | 2.84% |
| PEGY Ratio | 0.1175 |
| Operating PE Ratio | 25.55 |
| Normalized PE Ratio | 35.25 |